A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis

被引:5
|
作者
Pinilla-Monsalve, Gabriel D. [1 ]
Lores, Juliana [1 ,2 ]
Pachajoa, Harry [1 ,2 ]
Lopez-Ponce de Leon, Juan D. [1 ,3 ]
Lopez, Alejandro [1 ,4 ]
Rodriguez-Rojas, Lisa X. [1 ,2 ]
Nastasi-Catanese, Jose A. [1 ,2 ]
机构
[1] Univ Icesi, Fac Hlth Sci, Cali 760032, Colombia
[2] Fdn Valle del Lili, Dept Genet, Cali 760032, Colombia
[3] Fdn Valle del Lili, Dept Cardiol, Cali 760032, Colombia
[4] Fdn Valle del Lili, Dept Endocrinol, Cali 760032, Colombia
来源
关键词
hypertriglyceridemia; hyperlipoproteinemia type I; apolipoprotein C-II; pancreatitis; APOLIPOPROTEIN-C-II; DEFICIENCY; ESTROGEN;
D O I
10.2147/TACG.S243148
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [1] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jiang, Jingjing
    Wang, Yuhui
    Ling, Yan
    Kayoumu, Abudurexiti
    Liu, George
    Gao, Xin
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [2] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jingjing Jiang
    Yuhui Wang
    Yan Ling
    Abudurexiti Kayoumu
    George Liu
    Xin Gao
    Lipids in Health and Disease, 15
  • [3] Erratum to: A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jingjing Jiang
    Yuhui Wang
    Yan Ling
    Abudurexiti Kayoumu
    George Liu
    Xin Gao
    Lipids in Health and Disease, 15
  • [4] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis (vol 15, pg 12, 2016)
    Jiang, Jingjing
    Wang, Yuhui
    Ling, Yan
    Kayoumu, Abudurexiti
    Liu, George
    Gao, Xin
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [5] A NEW MUTATION IN APOC2 IN A MEXICAN PATIENT WITH DIABETES AND AUTISM SPECTRUM
    Gomez Aristizabal, L.
    Bravo Lopez, M.
    Carvajal Buenfil, E.
    Molina Diaz, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 39 - 39
  • [6] Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation
    Kose, Engin
    Armagan, Coskun
    Kisa, Pelin Teke
    Onay, Huseyin
    Arslan, Nur
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 31 (11): : 1289 - 1293
  • [7] A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis
    Ueda, Masako
    Dunbar, Richard L.
    Wolska, Anna
    Sikora, Tracey U.
    Escobar, Maria del Rosario
    Seliktar, Naomi
    deGoma, Emil
    DerOhannessian, Stephanie
    Morrell, Linda
    McIntyre, Adam D.
    Burke, Frances
    Sviridov, Denis
    Amar, Marcelo
    Shamburek, Robert D.
    Freeman, Lita
    Hegele, Robert A.
    Remaley, Alan T.
    Rader, Daniel J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05): : 1454 - 1457
  • [8] Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation
    Ueda, Masako
    Wolska, Anna
    Burke, Frances M.
    Escobar, Maria
    Walters, Laura
    Lalic, Dusanka
    Hegele, Robert A.
    Remaley, Alan T.
    Rader, Daniel J.
    Dunbar, Richard L.
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [9] Establishment and characterization of a novel inducible Apoc2 knockout mouse model to study the roles of Apoc2 in normal hematopoiesis
    Zhang, Xiaochen
    Chandwani, Ritu
    Pospiech, Mateusz
    Meng, Yiting
    Dhuri, Kanaka
    Thakker, Bhakti
    Ali, Atham
    Kadam, Shephali M.
    Wei, Yu-Chun
    Alachkar, Houda
    CANCER RESEARCH, 2024, 84 (06)
  • [10] APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target
    Zhang, Tian
    Vaikari, Vijaya Pooja
    Wu, Sharon
    Loza, Donna Alexandra
    Akhtari, Mojtaba
    Alachkar, Houda
    BLOOD, 2017, 130